Literature DB >> 9927972

Current options in management of head and neck cancer patients.

A J Correa1, B B Burkey.   

Abstract

Head and neck cancer, particularly squamous cell carcinoma (SCC) of the upper aerodigestive tract, poses difficult diagnostic and therapeutic challenges to the clinician. A methodical approach, including complete visualization of mucosal surfaces, appropriate imaging, and tissue diagnosis whenever possible, gives patients the best opportunity for early intervention. A treatment program of surgery, radiation, or chemotherapy is best developed by a devoted head and neck oncologic team, involving surgeons, radiation and medical oncologists, and rehabilitative specialists with significant experience in the care of head and neck oncologic patients. Despite new advancements in the treatment of patients with advanced stage SCC of the head and neck, little progress has been made in overall survival. Several new avenues of investigation are currently being explored, one of which may ultimately provide the answer for this devastating disease.

Entities:  

Mesh:

Year:  1999        PMID: 9927972     DOI: 10.1016/s0025-7125(05)70099-7

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  3 in total

1.  [Therapy options of advanced laryngeal carcinomas with regard to the quality of life of the patients].

Authors:  Elke Hayn; Martin Burian; Johannes Gobertus Meran
Journal:  Wien Med Wochenschr       Date:  2006-05

2.  Apparent diffusion coefficient mapping of the normal parotid gland and parotid involvement in patients with systemic connective tissue disorders.

Authors:  Rahul R Patel; Ruth C Carlos; Mehran Midia; Suresh K Mukherji
Journal:  AJNR Am J Neuroradiol       Date:  2004-01       Impact factor: 3.825

3.  Intraobserver variability in the MR determination of tumor volume in squamous cell carcinoma of the pharynx.

Authors:  Andrew R Gordon; Laurie A Loevner; Amita Shukla-Dave; Regina O Redfern; Adina I Sonners; Alex M Kilger; Mark A Elliott; Mitchell Machtay; Randal S Weber; Jerry D Glickson; David I Rosenthal
Journal:  AJNR Am J Neuroradiol       Date:  2004 Jun-Jul       Impact factor: 3.825

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.